COMPREHENSIVE AND COMPARATIVE FLOW CYTOMETRY-BASED METHODS FOR IDENTIFYING THE STATE OF A BIOLOGICAL SYSTEM
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Jun 23, 2016
app pub date -
Feb 2, 2015
filing date -
Dec 22, 2014
priority date (Note) -
Published
status (Latency Note)
![]() |
A preliminary load of PAIR data current through [] has been loaded. Any more recent PAIR data will be loaded within twenty-four hours. |
PAIR data current through []
A preliminary load of cached data will be loaded soon.
Any more recent PAIR data will be loaded within twenty-four hours.
![]() |
Next PAIR Update Scheduled on [ ] |

Importance

US Family Size
|
Non-US Coverage
|
Abstract
The present disclosure provides comprehensive and comparative flow cytometry-based methods for identifying the state of a biological system by identifying the phenotype of cells and correlating the phenotype with the gene expression profile of the cells, which is indicative of cell function. The cells can be immune cells from a subject suffering from immune-mediated disorders that result in imbalance of the immune system and impair a subject's ability to recognize self-antigens or fight infection or disease. In certain aspects, cell phenotype is identified by detecting and/or quantifying one or more markers on the cell surface or intracellularly, which readily enables identification of specific sub-types of cells of interest, which can then be analyzed for gene expression in order to assay cell function. In additional aspects, function of particular subsets of cells identified by cell surface markers is determined by detecting patterns of gene expression, expression of RNA or other markers, by detecting and/or quantifying transcription in the cell, by assaying DNA content, by assaying cell receptors, and/or by detecting the number and/or state of cellular organelles, receptors and/or transport systems.
First Claim
all claims..Other Claims data not available
Family

- 15 United States
- 10 France
- 8 Japan
- 7 China
- 5 Korea
- 2 Other
Patent Owner(s)
Patent Owner | Address | |
---|---|---|
ENZO BIOCHEM INC | 10 EXECUTIVE BLVD FARMINGDALE NY 11735 |
International Classification(s)

- 2015 Application Filing Year
- C12Q Class
- 3483 Applications Filed
- 2244 Patents Issued To-Date
- 64.43 % Issued To-Date
Inventor(s)
Inventor Name | Address | # of filed Patents | Total Citations |
---|---|---|---|
Donegan, James J | Long Beach, US | 138 | 1032 |
# of filed Patents : 138 Total Citations : 1032 | |||
L'Huillier, Andrew Stewart | Amity Harbor, US | 3 | 5 |
# of filed Patents : 3 Total Citations : 5 | |||
Rabbani, Elazar | New York, US | 186 | 2785 |
# of filed Patents : 186 Total Citations : 2785 |
Cited Art Landscape
- No Cited Art to Display

Patent Citation Ranking
- 5 Citation Count
- C12Q Class
- 46.01 % this patent is cited more than
- 9 Age
Forward Cite Landscape
- No Forward Cites to Display

Maintenance Fees
Fee | Large entity fee | small entity fee | micro entity fee | due date |
---|---|---|---|---|
11.5 Year Payment | $7400.00 | $3700.00 | $1850.00 | Dec 23, 2027 |
Fee | Large entity fee | small entity fee | micro entity fee |
---|---|---|---|
Surcharge - 11.5 year - Late payment within 6 months | $160.00 | $80.00 | $40.00 |
Surcharge after expiration - Late payment is unavoidable | $700.00 | $350.00 | $175.00 |
Surcharge after expiration - Late payment is unintentional | $1,640.00 | $820.00 | $410.00 |
Full Text

Legal Events
Date | Code | Event | Description |
---|---|---|---|
Apr 06, 2015 | STCH | INFORMATION ON STATUS: PATENT DISCONTINUATION | free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362 |
Mar 08, 2015 | FP | LAPSED DUE TO FAILURE TO PAY MAINTENANCE FEE | Effective Date: Mar 08, 2015 |
Mar 08, 2015 | LAPS | LAPSE FOR FAILURE TO PAY MAINTENANCE FEES | |
Oct 17, 2014 | REMI | MAINTENANCE FEE REMINDER MAILED | |
Mar 08, 2011 | I | Issuance | |
Sep 17, 2009 | P | Published | |
May 22, 2009 | F | Filing | |
May 22, 2009 | AS | ASSIGNMENT | free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:GORCZYNSKI, REGINALD M.;CLARK, DAVID A.;REEL/FRAME:022725/0966;SIGNING DATES FROM 20040819 TO 20040923 Owner name: TRILLIUM THERAPEUTICS INC., CANADA free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:GORCZYNSKI, REGINALD M.;CLARK, DAVID A.;SIGNING DATES FROM 20040819 TO 20040923;REEL/FRAME:022725/0966 Owner name: TRILLIUM THERAPEUTICS INC., CANADA |
Nov 07, 1997 | PD | Priority Date |

Matter Detail

Renewals Detail
